|By PR Newswire||
|March 7, 2014 11:25 AM EST||
DUBLIN, Mar. 07, 2014 /PRNewswire/ --
Research and Markets
) has announced the addition of the
report to their offering.
Defibrillator devices are used in treating life-threatening sudden cardiac arrest caused due to cardiac arrhythmias, particularly ventricular fibrillation and pulseless ventricular tachycardia. The global defibrillators market was valued at USD 9.3 billion in 2012, and is expected to grow at a CAGR of 6.2% to reach an estimated value of USD 14.2 billion by 2019. Sudden cardiac arrest is one of the major reasons for deaths across the globe with more than 300,000 deaths only in the United States alone. A defibrillator device depolarizes critical part of a heart muscle thereby helping in restoration of normal heart rhythm. If SCA victims receive cardiopulmonary resuscitation (CPR) and defibrillation within 5 to 12 minutes of cardiac arrest, many lives can be saved.
The most significant factors for the growth of global defibrillators market are -
- Growing incidences of cardiovascular diseases and disorders
- Aging of baby boomer population in the U.S.
- Increasing demand from emerging countries of Asia-Pacific and the Middle-East
- Increasing trend towards installations of AEDs at workplaces by businesses
The global defibrillators market has been segmented by product types, by end-users and by geography. On the basis of defibrillator types, the market is divided into advanced life support (ALS) defibrillators, automated external defibrillators (AEDs), implantable cardioverter defibrillators (ICDs) and wearable defibrillators. In 2012, implantable defibrillator devices accounted for the largest share by revenue of the global defibrillators market while the advanced life support defibrillators segment stood second in the global defibrillator market. The larger share of market is captured by implantable cardioverter defibrillators (ICDs) due to the rise in ICD implantations for preventing death from sudden cardiac arrest. Other factors such as accuracy in analyzing cardiac rhythm and quick response time for delivering shock are expected to drive the market in the near future.
The global defibrillators market is also segmented by end-users into hospitals, homes, public or community access, emergency medical services and business workplace. The defibrillators market was largely dominated by hospitals as end-user category contributing to more than 90% of the total market. The huge demand for defibrillators from hospitals is largely accounted for the ICD implantations and continuous demand for ALS defibrillators. In the near future, number of AED installations at large hospitals are expected to increase. In addition, the developing healthcare infrastructure in the emerging nations such as China, India and Brazil are expected to drive the demand for defibrillators.
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Global Defibrillators Market Overview
Chapter 4 Global Defibrillators Market, Size and Forecast, by Products, 2011 - 2019 Value (USD Million)
Chapter 5 Global Defibrillators Market, by End Users, Size and Forecast, 2011 - 2019 Value (USD Million)
Chapter 6 Global Defibrillators Market, by Geography, Size and Forecast, 2011 - 2019 Value (USD Million)
Chapter 7 Competitive Landscape
Chapter 8 Recommendations
Chapter 9 Company Profiles
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- Defibtech, LLC
- GE HEALTHCARE
- Heartsine Technologies, Inc.
- M EDTRONIC, INC.
- Mindray Medical International Limited
- Nihon Kohden Corporation
- Philips Healthcare
- Physio-Control, Inc.
- Schiller Ag
- Sorin Group
- St. Jude Medical Inc.
For more information visit http://www.researchandmarkets.com/research/wlj3vl/defibrillators
Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets